183 related articles for article (PubMed ID: 30445542)
1. Specific T-cell activation in peripheral blood and cerebrospinal fluid in central disorders of hypersomnolence.
Lippert J; Young P; Gross C; Meuth SG; Dräger B; Schirmacher A; Heidbreder A
Sleep; 2019 Feb; 42(2):. PubMed ID: 30445542
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of central disorders of hypersomnolence with manual and artificial-intelligence-derived polysomnographic measures.
Cesari M; Egger K; Stefani A; Bergmann M; Ibrahim A; Brandauer E; Högl B; Heidbreder A
Sleep; 2023 Feb; 46(2):. PubMed ID: 36455881
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence.
Barateau L; Jaussent I; Roeser J; Ciardiello C; Kilduff TS; Dauvilliers Y
Sleep; 2021 Jul; 44(7):. PubMed ID: 33476396
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease.
Moresco M; Lecciso M; Ocadlikova D; Filardi M; Melzi S; Kornum BR; Antelmi E; Pizza F; Mignot E; Curti A; Plazzi G
Sleep Med; 2018 Apr; 44():53-60. PubMed ID: 29530370
[TBL] [Abstract][Full Text] [Related]
5. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.
Lopez R; Doukkali A; Barateau L; Evangelista E; Chenini S; Jaussent I; Dauvilliers Y
Sleep; 2017 Dec; 40(12):. PubMed ID: 29099966
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin-type prostaglandin D synthase levels increase in patients with narcolepsy and idiopathic hypersomnia.
Wang P; Li Q; Dong X; An H; Li J; Zhao L; Yan H; Aritake K; Huang Z; Strohl KP; Urade Y; Zhang J; Han F
Sleep; 2021 Apr; 44(4):. PubMed ID: 33175978
[TBL] [Abstract][Full Text] [Related]
7. Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.
Lecendreux M; Churlaud G; Pitoiset F; Regnault A; Tran TA; Liblau R; Klatzmann D; Rosenzwajg M
PLoS One; 2017; 12(1):e0169836. PubMed ID: 28107375
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
[TBL] [Abstract][Full Text] [Related]
9. Cognitive dysfunction in central disorders of hypersomnolence: A systematic review.
Filardi M; D'Anselmo A; Agnoli S; Rubaltelli E; Mastria S; Mangiaruga A; Franceschini C; Pizza F; Corazza GE; Plazzi G
Sleep Med Rev; 2021 Oct; 59():101510. PubMed ID: 34166991
[TBL] [Abstract][Full Text] [Related]
10. Disease-specific attention impairment in disorders of chronic excessive daytime sleepiness.
Ramm M; Boentert M; Lojewsky N; Jafarpour A; Young P; Heidbreder A
Sleep Med; 2019 Jan; 53():133-140. PubMed ID: 30508781
[TBL] [Abstract][Full Text] [Related]
11. Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations.
Gool JK; Zhang Z; Fronczek R; Amesz P; Khatami R; Lammers GJ
Sleep Med; 2024 Apr; 116():105-114. PubMed ID: 38442518
[TBL] [Abstract][Full Text] [Related]
12. Comparative polysomnography parameters between narcolepsy type 1/type 2 and idiopathic hypersomnia: A systematic review and meta-analysis.
Zhang Y; Ren R; Yang L; Zhang H; Shi Y; Vitiello MV; Tang X; Sanford LD
Sleep Med Rev; 2022 Jun; 63():101610. PubMed ID: 35278894
[TBL] [Abstract][Full Text] [Related]
13. Decreased sleep stage transition pattern complexity in narcolepsy type 1.
Ferri R; Pizza F; Vandi S; Iloti M; Plazzi G
Clin Neurophysiol; 2016 Aug; 127(8):2812-2819. PubMed ID: 27417057
[TBL] [Abstract][Full Text] [Related]
14. The transcriptomics profiling of blood CD4 and CD8 T-cells in narcolepsy type I.
Khajavi L; Nguyen XH; Queriault C; Chabod M; Barateau L; Dauvilliers Y; Zytnicki M; Liblau R
Front Immunol; 2023; 14():1249405. PubMed ID: 38077397
[TBL] [Abstract][Full Text] [Related]
15. On-the-road driving performance of patients with central disorders of hypersomnolence.
van der Sluiszen NNJJM; Urbanus B; Lammers GJ; Overeem S; Ramaekers JG; Vermeeren A
Traffic Inj Prev; 2021; 22(2):120-126. PubMed ID: 33543997
[TBL] [Abstract][Full Text] [Related]
16. Distribution of HLA-DQB1 in Czech Patients with Central Hypersomnias.
Vrana M; Siffnerova V; Pecherkova P; Ratajova E; Sonka K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):89-98. PubMed ID: 28083611
[TBL] [Abstract][Full Text] [Related]
17. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence.
Maski KP; Colclasure A; Little E; Steinhart E; Scammell TE; Navidi W; Diniz Behn C
Sleep; 2021 Jul; 44(7):. PubMed ID: 33512510
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal Sleep Dynamics Identify Narcolepsy Type 1.
Pizza F; Vandi S; Iloti M; Franceschini C; Liguori R; Mignot E; Plazzi G
Sleep; 2015 Aug; 38(8):1277-84. PubMed ID: 25845690
[TBL] [Abstract][Full Text] [Related]
19. Peripheral leukocytes with HLA-DR+/CD8- phenotype are associated with prognosis in patients with lung cancer.
Nakamura H; Saji H; Aute I; Kawasaki N; Hosaka M; Ogata A; Saijo T; Kato H
Anticancer Res; 2003; 23(5b):4149-52. PubMed ID: 14666616
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity between central disorders of hypersomnolence and immune-based disorders.
Barateau L; Lopez R; Arnulf I; Lecendreux M; Franco P; Drouot X; Leu-Semenescu S; Jaussent I; Dauvilliers Y
Neurology; 2017 Jan; 88(1):93-100. PubMed ID: 27864522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
